Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Uromune (MV140) / Inmunotek
NCT04096820: Uromune in Treating Recurrent Urinary Tract Infections in Women	Terminated	2	67	Canada	Uromune	Queen's University	Recurrent Uti	10/22	01/23
NCT04173013: Expanded Access Program Using Uromune for Patients With Recurrent Urinary Tract Infections (rUTI)	No Longer Available	N/A		Europe, RoW	Uromune, MV140	Impatients N.V. trading as myTomorrows, Inmunotek S.L.	Urinary Tract Infections, Chronic Urinary Tract Infection, Recurrent Urinary Tract Infection, Urinary Tract Infection Bacterial, Bladder Infection